Manifestações cutâneas no lúpus eritematoso
o que o clínico precisa saber
Palavras-chave:
Lúpus eritematoso cutâneo, lúpus eritematoso discoide, lúpus eritematoso sistêmico, paniculite de lúpus eritematoso, dermatologiaResumo
O lúpus eritematoso é uma doença autoimune complexa que afeta diversos órgãos. A pele é o segundo local mais acometido e as manifestações cutâneas são divididas em específicas e não específicas. As primeiras possuem em comum o achado histopatológico de dermatite de interface com degeneração vacuolar da camada basal e infiltrado linfocitário na junção dermoepidérmica e são subdivididas em agudas, subagudas e crônicas. As manifestações não específicas compõem um grupo heterogêneo de condições que frequentemente está associado ao lúpus eritematoso sistêmico. O conhecimento e a interpretação adequada de tais manifestações é importante, pois, além da relevância diagnóstica, as lesões cutâneas nos dão informações prognósticas. Portanto, é imprescindível que o clínico conheça as principais manifestações cutâneas do lúpus eritematoso para a melhor condução desses pacientes.
Referências
Lee HJ, Sinha AA. Cutaneous lupus erythematosus: understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies. Autoimmunity. 2006;39(6):433-44. PMID: 17060022; https://doi.org/10.1080/08916930600886851.
Jarukitsopa S, Hoganson DD, Crowson CS, et al. Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States. Arthritis Care Res (Hoboken). 2015;67(6):817-28. PMID: 25369985; https://doi.org/10.1002/acr.22502.
Petersen MP, Möller S, Bygum A, Voss A, Bliddal MEpidemiology of cutaneous lupus erythematosus and the associated risk of systemic lupus erythematosus: a nationwide cohort study in Denmark. Lupus. 2018;27(9):1424-1430. PMID: 29788808; https://doi.org/10.1177/0961203318777103.
Gilliam JN, Sontheimer RD. Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol. 1981;4(4):471-5. PMID: 7229150; https://doi.org/10.1016/s0190-9622(81)80261-7.
Callen JP. Cutaneous lupus erythematosus: Reflecting on practice-changing observations over the past 50 years. Clin Dermatol. 2018;36(4):442-9. PMID: 30047428; https://doi.org/10.1016/j.clindermatol.2018.04.002.
Biazar C, Sigges J, Patsinakidis N, et al. Cutaneous lupus erythematosus: first multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE). Autoimmun Rev. 2013;12(3):444-54. PMID: 23000206; https://doi.org/10.1016/j.autrev.2012.08.019.
Watanabe T, Tsuchida T. Classification of lupus erythematosus based upon cutaneous manifestations. Dermatological, systemic and laboratory findings in 191 patients. Dermatology. 1995;190(4):277-83. PMID: 7655105; https://doi.org/10.1159/000246716.
Kuhn A, Landmann A. The classification and diagnosis of cutaneous lupus erythematosus. J Autoimmun. 2014;48-49:14-9. PMID: 24486120; https://doi.org/10.1016/j.jaut.2014.01.021.
Mainetti C, Terziroli Beretta-Piccoli B, Selmi C. Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review. Clin Rev Allergy Immunol. 2017;53(3):337-56. PMID: 29090371; https://doi.org/10.1007/s12016-017-8652-1.
Wenzel J. Cutaneous lupus erythematosus: new insights into pathogenesis and therapeutic strategies. Nat Rev Rheumatol. 2019;15(9):519-32. PMID: 31399711; https://doi.org/10.1038/s41584-019-0272-0.
Alves F, Gonçalo M. Lupus Erythematosus: Cutaneous Manifestations and Treatment. Journal of the Portuguese Society of Dermatology and Venereology. 2019;77(3):201-14. https://doi.org/10.29021/spdv.77.3.1118.
Rothfield N, Sontheimer RD, Bernstein M. Lupus erythematosus: systemic and cutaneous manifestations. Clin Dermatol. 2006;24(5):348-62. PMID: 16966017; https://doi.org/10.1016/j.clindermatol.2006.07.014.
Udompanich S, Chanprapaph K, Suchonwanit P. Hair and Scalp Changes in Cutaneous and Systemic Lupus Erythematosus. Am J Clin Dermatol. 2018;19(5):679-94. PMID: 29948959; https://doi.org/10.1007/s40257-018-0363-8.
Chiewchengchol D, Murphy R, Edwards SW, Beresford MW. Mucocutaneous manifestations in juvenile-onset systemic lupus erythematosus: a review of literature. Pediatr Rheumatol Online J. 2015;13:1. PMID: 25587243; https://doi.org/10.1186/1546-0096-13-1.
Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019;71(9):1400-12. PMID: 31385462; https://doi.org/10.1002/art.40930.
Tankunakorn J, Sawatwarakul S, Vachiramon V, Chanprapaph K. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis-Like Lupus Erythematosus. J Clin Rheumatol. 2019;25(5):224-31. PMID: 29912772; https://doi.org/10.1097/rhu.0000000000000830.
Okon LG, Werth VP. Cutaneous lupus erythematosus: diagnosis and treatment. Best Pract Res Clin Rheumatol. 2013;27(3):391-404. PMID: 24238695; https://doi.org/10.1016/j.berh.2013.07.008.
Parodi A, Caproni M, Cardinali C, et al. Clinical, histological and immunopathological features of 58 patients with subacute cutaneous lupus erythematosus. A review by the Italian group of immunodermatology. Dermatology. 2000;200(1):6-10. PMID: 10681606;https://doi.org/10.1159/000018307.
Niebel D, Braegelmann C, Bieber T, Wenzel J. Vitiligo-like depigmentation subsequent to subacute cutaneous lupus erythematosus and hydroxychloroquine treatment. J Dtsch Dermatol Ges. 2020;18(12):1470-3. PMID: 32783375; https://doi.org/10.1111/ddg.14221.
Pelka K, Stec-Polak M, Wojas-Pelc A, Pastuszczak M. Prevalence of antimitochondrial antibodies in subacute cutaneous lupus erythematosus. Int J Dermatol. 2021;60(1):88-92. PMID: 33017043; https://doi.org/10.1111/ijd.15225.
Guicciardi F, Atzori L, Marzano AV, et al. Are there distinct clinical and pathological features distinguishing idiopathic from drug-induced subacute cutaneous lupus erythematosus? A European retrospective multicenter study. J Am Acad Dermatol. 2019;81(2):403-11. PMID: 30763648; https://doi.org/10.1016/j.jaad.2019.02.009.
Chong BF, Song J, Olsen NJ. Determining risk factors for developing systemic lupus erythematosus in patients with discoid lupus erythematosus. Br J Dermatol. 2012;166(1):29-35. PMID: 21910708; https://doi.org/10.1111/j.1365-2133.2011.10610.x.
Callen JP. Systemic lupus erythematosus in patients with chronic cutaneous (discoid) lupus erythematosus. Clinical and laboratory findings in seventeen patients. J Am Acad Dermatol. 1985;12(2 Pt 1):278-88. PMID: 3871800; https://doi.org/10.1016/s0190-9622(85)80036-0.
Merola JF, Prystowsky SD, Iversen C, et al. Association of discoid lupus erythematosus with other clinical manifestations among patients with systemic lupus erythematosus. J Am Acad Dermatol. 2013;69(1):19-24. PMID: 23541758; https://doi.org/10.1016/j.jaad.2013.02.010.
Pons-Estel GJ, Aspey LD, Bao G, et al. Early discoid lupus erythematosus protects against renal disease in patients with systemic lupus erythematosus: longitudinal data from a large Latin American cohort. Lupus. 2017;26(1):73-83. PMID: 27230554; https://doi.org/10.1177/0961203316651740.
Prenner J, Kelley K, Elkeeb D, Onajin O. Hypertrophic Discoid Lupus Erythematosus of the Vulva Mimicking Lichen Simplex Chronicus: A Case Report and Review of the Literature. Am J Dermatopathol. 2020;42(3):191-5. PMID: 31725484; https://doi.org/10.1097/dad.0000000000001549.
Daldon PE, Macedo de Souza E, Cintra ML. Hypertrophic lupus erythematosus: a clinicopathological study of 14 cases. J Cutan Pathol. 2003;30(7):443-8. PMID: 12859742; https://doi.org/10.1034/j.1600-0560.2003.00082.x.
Rangel LK, Villa-Ruiz C, Lo K, et al. Clinical Characteristics of Lupus Erythematosus Panniculitis/Profundus: A Retrospective Review of 61 Patients. JAMA Dermatol. 2020;156(11):1264-6. PMID: 32876656; https://doi.org/10.1001/jamadermatol.2020.2797.
González-Cruz C, Aparicio Español G, Ferrer Fàbrega B, et al. Lupus panniculitis: Clinicopathological features of a series of 12 patients. Med Clin (Barc). 2018;151(11):444-9. PMID: 30154008; https://doi.org/10.1016/j.medcli.2018.06.024.
Juczynska K, Wozniacka A, Waszczykowska E, Zebrowska A. Lupus erythematosus panniculitis resistant to standard treatment, complicated with macrophage activation syndrome. Postepy Dermatol Alergol. 2017;34(3):281-3. PMID: 28670262; https://doi.org/10.5114/ada.2017.67852.
Kuhn A, Richter-Hintz D, Oslislo C, et al. Lupus erythematosus tumidus − a neglected subset of cutaneous Lupus erythematosus: report of 40 cases. Arch Dermatol. 2000;136(8):1033-41. PMID: 10926740; https://doi.org/10.1001/archderm.136.8.1033.
Kuhn A, Bein D, Bonsmann G. The 100th anniversary of lupus erythematosus tumidus. Autoimmun Rev. 2009;8(6):441-8. PMID: 19162244; https://doi.org/10.1016/j.autrev.2008.12.010.
Hedrich CM, Fiebig B, Hauck FH, et al. Chilblain lupus erythematosus − a review of literature. Clin Rheumatol. 2008;27(8):949-54. PMID: 18543054; https://doi.org/10.1007/s10067-008-0942-9.
Viguier M, Pinquier L, Cavelier-Balloy B, et al. Clinical and histopathologic features and immunologic variables in patients with severe chilblains. A study of the relationship to lupus erythematosus. Medicine (Baltimore). 2001;80(3):180-8. PMID: 11388094; https://doi.org/10.1097/00005792-200105000-00004.
Kuhn A, Wenzel J, Bijl M. Lupus erythematosus revisited. Semin Immunopathol. 2016;38(1):97-112. PMID: 26637330; https://doi.org/10.1007/s00281-015-0550-0.
Ramos-Casals M, Nardi N, Lagrutta M, et al. Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients. Medicine (Baltimore). 2006;85(2):95-104. PMID: 16609348; https://doi.org/10.1097/01.md.0000216817.35937.70.
Cutolo M, Melsens K, Wijnant S, et al. Nailfold capillaroscopy in systemic lupus erythematosus: A systematic review and critical appraisal. Autoimmun Rev. 2018;17(4):344-52. PMID: 29427827;https://doi.org/10.1016/j.autrev.2017.11.025.
Gusdorf L, Bessis D, Lipsker D. Lupus erythematosus and neutrophilic urticarial dermatosis: a retrospective study of 7 patients. Medicine (Baltimore). 2014;93(29):e351. PMID: 25546692; https://doi.org/10.1097/md.0000000000000351.
Blake SC, Daniel BS. Cutaneous lupus erythematosus: A review of the literature. Int J Womens Dermatol. 2019;5(5):320-9. PMID: 31909151; https://doi.org/10.1016/j.ijwd.2019.07.004.
